COSCIENS Biopharma Inc.
CSCIF
$4.98
-$0.32-6.04%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.45% | -31.50% | -14.28% | -8.67% | -32.16% |
| Total Receivables | 18.91% | 58.13% | -21.43% | -42.33% | 49.70% |
| Inventory | -12.65% | -15.91% | -25.70% | -3.40% | -25.82% |
| Prepaid Expenses | -14.15% | -60.31% | 117.21% | -27.87% | 34.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -38.89% | -58.30% | -54.56% | -13.24% | -23.60% |
| Total Current Assets | 3.20% | -18.32% | -16.88% | -16.17% | -18.92% |
|
|
|||||
| Total Current Assets | 3.20% | -18.32% | -16.88% | -16.17% | -18.92% |
| Net Property, Plant & Equipment | -5.35% | -5.73% | -0.87% | -9.44% | 2.48% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.98% | 61.60% | -5.30% | 0.00% | 3.13% |
| Total Assets | 0.05% | -12.09% | -10.18% | -13.42% | -11.51% |
|
|
|||||
| Total Accounts Payable | -9.76% | -20.27% | -27.67% | -32.90% | -46.25% |
| Total Accrued Expenses | -20.18% | -70.83% | 23.29% | -39.83% | -19.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.54% | -13.49% | 1.42% | 1.44% | -17.39% |
| Total Finance Division Other Current Liabilities | 118.50% | -88.34% | 170.24% | -20.96% | 12.36% |
| Total Other Current Liabilities | 118.50% | -88.34% | 170.24% | -20.96% | 12.36% |
| Total Current Liabilities | 32.94% | -53.36% | -9.29% | -28.59% | -20.98% |
|
|
|||||
| Total Current Liabilities | 32.94% | -53.36% | -9.29% | -28.59% | -20.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.70% | -5.02% | -1.28% | -4.39% | 3.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -6.19% | 0.02% | 7.26% |
| Total Liabilities | 13.83% | -79.98% | -6.34% | -8.22% | -2.55% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.01% | 0.10% | 0.43% |
| Retained Earnings | -2.07% | 52.45% | -7.66% | -10.57% | -17.55% |
| Treasury Stock & Other | -11.25% | 41.66% | 14.61% | -12.65% | -24.91% |
| Total Common Equity | -3.11% | 298.72% | -24.37% | -28.42% | -30.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.11% | 298.72% | -24.37% | -28.42% | -30.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.11% | 298.72% | -24.37% | -28.42% | -30.04% |
|
|
|||||